The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression

BackgroundCutaneous T-cell lymphoma (CTCL) is a heterogeneous group of T-cell lymphomas characterized with the presence of clonal malignant T cells. Mycosis fungoides (MF) is the most common type of CTCL. However, the pathogenesis of MF and the role of the tumor microenvironment (TME) remain unclear...

Full description

Saved in:
Bibliographic Details
Main Authors: Yige Zhao, Yong Li, Panpan Wang, Mengyan Zhu, Jiaqi Wang, Bo Xie, Chenyu Tang, Yangyang Ma, Shiwen Wang, Sha Jin, Jinhui Xu, Zhao Li, Xiaoyan Zhang, Liuyu Li, Xiuzu Song, Ping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1474564/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548216742084608
author Yige Zhao
Yong Li
Yong Li
Panpan Wang
Mengyan Zhu
Jiaqi Wang
Bo Xie
Chenyu Tang
Yangyang Ma
Shiwen Wang
Sha Jin
Jinhui Xu
Zhao Li
Xiaoyan Zhang
Liuyu Li
Xiuzu Song
Ping Wang
author_facet Yige Zhao
Yong Li
Yong Li
Panpan Wang
Mengyan Zhu
Jiaqi Wang
Bo Xie
Chenyu Tang
Yangyang Ma
Shiwen Wang
Sha Jin
Jinhui Xu
Zhao Li
Xiaoyan Zhang
Liuyu Li
Xiuzu Song
Ping Wang
author_sort Yige Zhao
collection DOAJ
description BackgroundCutaneous T-cell lymphoma (CTCL) is a heterogeneous group of T-cell lymphomas characterized with the presence of clonal malignant T cells. Mycosis fungoides (MF) is the most common type of CTCL. However, the pathogenesis of MF and the role of the tumor microenvironment (TME) remain unclear.MethodsWe performed single-cell RNA sequencing on tumor and adjacent normal tissues and peripheral blood mononuclear cell (PBMC) from patients with advanced MF and healthy control (HC). We compared skin lesions in different stages within the same patient to overcome inter-individual variability.ResultsThe malignant clones displayed dual phenotypes characterized with tissue-resident memory T cells (TRMs) and central memory T cells (TCMs). We supposed that the tumor cells transformed from TRM-dominant phenotype to TCM-dominant phenotype during MF progressed from early-stage to advanced-stage. The cancer-associated fibroblasts (CAFs) showed active role in TME. The occurrence of inflammatory CAFs (iCAFs) may represent the advanced-stage MF. There may be mutual positive feedback of the crosstalk between tumor cells and CAFs during the MF development. Tumor cells promote CAF generation, and the CAFs, in turn, improve the invasiveness and metastasis of the malignant T cells through the IL-6/JAK2/STAT3/SOX4 or IL-6/HIF-1α/SOX4 pathway. SOX4 may be a critical regulatory gene of this positive feedback loop. Target SOX4 may disrupt the interactions between tumor cells and CAFs.ConclusionOur study revealed the origin and evolution trajectory of MF and uncovered the intercellular interactions between malignant T cells and CAFs, providing new insights into the novel treatment targets of MF.
format Article
id doaj-art-bc829f311aef41ec8513514e715283ef
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-bc829f311aef41ec8513514e715283ef2025-02-03T06:33:48ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011510.3389/fimmu.2024.14745641474564The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progressionYige Zhao0Yong Li1Yong Li2Panpan Wang3Mengyan Zhu4Jiaqi Wang5Bo Xie6Chenyu Tang7Yangyang Ma8Shiwen Wang9Sha Jin10Jinhui Xu11Zhao Li12Xiaoyan Zhang13Liuyu Li14Xiuzu Song15Ping Wang16Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaResearch Center, Shanghai Yeslab Biotechnology, Shanghai, ChinaDepartment of Dermatology, Shaoxing People's Hospital, Shaoxing, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, ChinaBackgroundCutaneous T-cell lymphoma (CTCL) is a heterogeneous group of T-cell lymphomas characterized with the presence of clonal malignant T cells. Mycosis fungoides (MF) is the most common type of CTCL. However, the pathogenesis of MF and the role of the tumor microenvironment (TME) remain unclear.MethodsWe performed single-cell RNA sequencing on tumor and adjacent normal tissues and peripheral blood mononuclear cell (PBMC) from patients with advanced MF and healthy control (HC). We compared skin lesions in different stages within the same patient to overcome inter-individual variability.ResultsThe malignant clones displayed dual phenotypes characterized with tissue-resident memory T cells (TRMs) and central memory T cells (TCMs). We supposed that the tumor cells transformed from TRM-dominant phenotype to TCM-dominant phenotype during MF progressed from early-stage to advanced-stage. The cancer-associated fibroblasts (CAFs) showed active role in TME. The occurrence of inflammatory CAFs (iCAFs) may represent the advanced-stage MF. There may be mutual positive feedback of the crosstalk between tumor cells and CAFs during the MF development. Tumor cells promote CAF generation, and the CAFs, in turn, improve the invasiveness and metastasis of the malignant T cells through the IL-6/JAK2/STAT3/SOX4 or IL-6/HIF-1α/SOX4 pathway. SOX4 may be a critical regulatory gene of this positive feedback loop. Target SOX4 may disrupt the interactions between tumor cells and CAFs.ConclusionOur study revealed the origin and evolution trajectory of MF and uncovered the intercellular interactions between malignant T cells and CAFs, providing new insights into the novel treatment targets of MF.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1474564/fullmycosis fungoides (MF)cutaneous T cell lymphoma (CTCL)tissue resident memory T cell (TRM)cancer-associated fibroblast (CAF)tumor microenvironmentSOX4
spellingShingle Yige Zhao
Yong Li
Yong Li
Panpan Wang
Mengyan Zhu
Jiaqi Wang
Bo Xie
Chenyu Tang
Yangyang Ma
Shiwen Wang
Sha Jin
Jinhui Xu
Zhao Li
Xiaoyan Zhang
Liuyu Li
Xiuzu Song
Ping Wang
The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
Frontiers in Immunology
mycosis fungoides (MF)
cutaneous T cell lymphoma (CTCL)
tissue resident memory T cell (TRM)
cancer-associated fibroblast (CAF)
tumor microenvironment
SOX4
title The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
title_full The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
title_fullStr The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
title_full_unstemmed The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
title_short The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
title_sort cancer associated fibroblasts interact with malignant t cells in mycosis fungoides and promote the disease progression
topic mycosis fungoides (MF)
cutaneous T cell lymphoma (CTCL)
tissue resident memory T cell (TRM)
cancer-associated fibroblast (CAF)
tumor microenvironment
SOX4
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1474564/full
work_keys_str_mv AT yigezhao thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yongli thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yongli thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT panpanwang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT mengyanzhu thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT jiaqiwang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT boxie thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT chenyutang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yangyangma thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT shiwenwang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT shajin thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT jinhuixu thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT zhaoli thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT xiaoyanzhang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT liuyuli thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT xiuzusong thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT pingwang thecancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yigezhao cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yongli cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yongli cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT panpanwang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT mengyanzhu cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT jiaqiwang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT boxie cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT chenyutang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT yangyangma cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT shiwenwang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT shajin cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT jinhuixu cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT zhaoli cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT xiaoyanzhang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT liuyuli cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT xiuzusong cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression
AT pingwang cancerassociatedfibroblastsinteractwithmalignanttcellsinmycosisfungoidesandpromotethediseaseprogression